but was not affected by addition of ß1 integrin antibody (Fig. 6d). By contrast, a neutralizing antibody specific for VEGF receptor 2 (VEGFR2) did not affect lactadherin-induced AKT ...
The decision affects THR-687, a pan RGD integrin antagonist for the treatment ... who do not respond to treatment with blockbuster anti-VEGF drugs like Bayer/Regeneron's Eylea (aflibercept ...
As a proof-of-principle, we screened human endothelial cells stimulated with vascular endothelial growth factor (VEGF ... assays with a defined α v integrin phage ligand and phage-cell–binding ...
One of the most promising antiangiogenic treatments is the anti-VEGF monoclonal antibody (mAb) bevacizumab (also known as rhuMAb-VEGF and marketed as Avastin ® by Genentech Inc., South San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback